av/genmab-a-s--big.svg

COM:GENMAB

Genmab A/S

  • Stock

Last Close

1,447.50

22/11 15:59

Market Cap

116.34B

Beta: -

Volume Today

53.53K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-43M
-
average payables
39.90M
-
15.99M
-
27.13M
69.62%
11.14M
58.96%
175M
-
175M
0%
2.01B
1,049.43%
average receivables
136.35M
-
120.92M
11.31%
140.25M
15.98%
575.17M
310.10%
806.18M
40.16%
981.81M
21.79%
2.16B
119.85%
2.85B
32.08%
3.06B
7.16%
4.73B
54.68%
5.50B
16.39%
book value per share
12.94
-
36.10
179.03%
59.58
65.05%
80.61
35.30%
103.10
27.90%
130.81
26.87%
223.12
70.57%
293.36
31.48%
339.41
15.70%
419.67
23.65%
479.56
14.27%
capex per share
-0.20
-
-1.34
558.86%
-2.31
72.70%
-0.55
76.10%
-1.45
163.12%
-7.79
435.52%
-1.76
77.37%
-4.71
167.17%
-3.85
18.19%
-4.85
25.81%
-5.70
17.66%
capex to depreciation
-0.89
-
-6.12
588.48%
-4.25
30.46%
-0.81
81.00%
-1.27
56.97%
-5.45
329.46%
-0.80
85.35%
-1.19
48.43%
-1.02
14.27%
-0.88
13.82%
-1.27
45.55%
capex to operating cash flow
0.08
-
-0.57
802.22%
-0.43
23.55%
-0.10
76.76%
-0.06
44.86%
-0.47
744.50%
-0.08
82.20%
-0.05
42.99%
-0.11
137.01%
-0.08
28.36%
-0.05
37.13%
capex to revenue
-0.02
-
-0.09
467.96%
-0.12
34.69%
-0.02
84.74%
-0.04
105.25%
-0.16
321.72%
-0.02
86.89%
-0.03
46.78%
-0.03
2.15%
-0.02
26.89%
-0.02
5.08%
cash per share
30.54
-
47.24
54.68%
59.69
26.35%
65.50
9.73%
89.14
36.09%
99.66
11.80%
174.25
74.84%
246.69
41.58%
295.71
19.87%
341.41
15.46%
426.84
25.02%
days of inventory on hand
92.06
-
days payables outstanding
3.73K
-
days sales outstanding
74.81
-
45.43
39.28%
56.27
23.86%
196.09
248.51%
98.24
49.90%
160.10
62.96%
203.38
27.03%
97.90
51.86%
146.22
49.36%
151.38
3.52%
109.61
27.59%
debt to assets
0.00
-
0.00
91.37%
0.00
75.58%
0.01
38,799.72%
0.01
-
0.02
26.24%
0.02
14.38%
0.02
14.25%
0.02
10.66%
debt to equity
0.00
-
0.00
95.37%
0.00
80.62%
0.01
37,618.15%
0.01
-
0.02
29.48%
0.02
14.77%
0.02
13.62%
0.02
11.97%
dividend yield
0.00
-
earnings yield
0.01
-
0.01
128.75%
0.01
4.24%
0.02
18.86%
0.02
1.45%
0.02
36.79%
0.02
0.99%
0.03
27.64%
0.02
40.99%
0.03
64.19%
0.03
6.70%
enterprise value
10.64B
-
19.93B
87.30%
52.82B
165.00%
69.93B
32.39%
63.01B
9.89%
62.24B
1.24%
89.91B
44.46%
153.59B
70.83%
163.46B
6.42%
183.01B
11.96%
127.95B
30.09%
enterprise value over ebitda
86.80
-
63.53
26.81%
66.90
5.31%
59.70
10.77%
55.46
7.10%
36.61
33.99%
31.04
15.23%
22.73
26.75%
47.20
107.62%
25.98
44.95%
19.52
24.88%
ev to operating cash flow
-83.14
-
150.23
280.70%
169.59
12.89%
213.38
25.82%
39.66
81.41%
61.33
54.65%
67.80
10.56%
23.88
64.79%
73.37
207.28%
46.78
36.24%
17.34
62.94%
ev to sales
16.04
-
23.44
46.15%
46.62
98.89%
38.50
17.40%
26.64
30.81%
20.57
22.77%
16.76
18.56%
15.19
9.34%
19.27
26.86%
12.54
34.93%
7.77
38.06%
free cash flow per share
-2.71
-
1.02
137.44%
3.01
196.04%
4.92
63.55%
24.66
401.28%
8.77
64.44%
19.30
119.99%
93.99
387.05%
30.22
67.85%
54.98
81.96%
106.26
93.27%
free cash flow yield
-0.01
-
0.00
122.03%
0.00
16.26%
0.00
27.92%
0.02
455.77%
0.01
63.27%
0.01
52.13%
0.04
192.96%
0.01
69.89%
0.02
62.72%
0.05
163.76%
graham net net
11.51
-
33.85
193.96%
54.82
61.97%
70.85
29.23%
91.55
29.22%
108.62
18.64%
192.45
77.19%
246.87
28.28%
297.50
20.51%
367.45
23.51%
427.75
16.41%
graham number
20.02
-
65.92
229.36%
132.25
100.62%
189.63
43.39%
205.14
8.18%
265.93
29.63%
415.57
56.27%
694.15
67.03%
592.68
14.62%
892.99
50.67%
844.05
5.48%
income quality
-1.19
-
0.45
137.52%
0.41
7.85%
0.29
29.47%
1.49
415.17%
0.63
57.86%
0.46
26.33%
1.09
134.93%
0.56
48.66%
0.56
0.59%
1.31
135.44%
intangibles to total assets
0.00
-
0.02
1,386.39%
0.05
126.30%
0.03
29.66%
0.02
45.75%
0.06
195.08%
0.03
44.17%
0.02
48.49%
0.01
35.48%
0.00
53.25%
0.00
40.65%
interest coverage
29.42
-
65.41
122.30%
6.19K
9,362.68%
4.94K
20.14%
479.72
90.29%
3.31K
589.99%
376.86
88.61%
631.30
67.52%
232.15
63.23%
302.71
30.39%
197.07
34.90%
interest debt per share
0.11
-
0.08
31.32%
0.00
94.85%
1.03
25,504.19%
0.05
95.54%
0.01
85.22%
2.99
43,770.38%
5.05
69.05%
6.70
32.69%
9.45
41.11%
12.09
27.93%
inventory turnover
3.96
-
invested capital
0.00
-
0.00
95.37%
0.00
80.62%
0.01
37,618.15%
0.01
-
0.02
29.48%
0.02
14.77%
0.02
13.62%
0.02
11.97%
market cap
10.81B
-
20.29B
87.75%
53.69B
164.62%
70.23B
30.81%
64.36B
8.36%
62.77B
2.48%
93.28B
48.61%
160.54B
72.10%
171.99B
7.14%
192.30B
11.81%
142.05B
26.13%
net current asset value
620.98M
-
1.93B
211.22%
3.25B
68.27%
4.49B
37.95%
5.73B
27.70%
6.99B
21.95%
12.87B
84.14%
16.77B
30.35%
20.30B
21.09%
25.54B
25.78%
29.46B
15.35%
net debt to ebitda
-1.35
-
-1.14
15.37%
-1.11
3.19%
-0.26
76.32%
-1.19
352.47%
-0.31
73.57%
-1.16
271.20%
-1.03
11.71%
-2.46
139.81%
-1.32
46.43%
-2.15
62.94%
net income per share
1.38
-
5.35
288.76%
13.05
143.86%
19.83
51.96%
18.14
8.50%
24.03
32.46%
34.40
43.17%
73.00
112.20%
46.00
36.99%
84.45
83.60%
66.02
21.82%
operating cash flow per share
-2.51
-
2.36
193.83%
5.32
125.90%
5.47
2.84%
26.12
377.22%
16.56
36.59%
21.06
27.15%
98.70
368.65%
34.07
65.48%
59.83
75.61%
111.96
87.14%
payables turnover
0.10
-
receivables turnover
4.88
-
8.03
64.68%
6.49
19.26%
1.86
71.31%
3.72
99.59%
2.28
38.64%
1.79
21.28%
3.73
107.74%
2.50
33.05%
2.41
3.40%
3.33
38.11%
research and ddevelopement to revenue
0.80
-
0.59
25.21%
0.43
27.62%
0.36
15.45%
0.37
1.57%
0.47
28.00%
0.44
6.01%
0.31
30.22%
0.49
58.88%
0.38
22.69%
0.46
21.53%
return on tangible assets
0.04
-
0.11
164.80%
0.21
91.54%
0.23
14.07%
0.17
27.44%
0.18
8.16%
0.15
19.88%
0.23
54.93%
0.12
46.04%
0.18
48.49%
0.12
32.51%
revenue per share
13.02
-
15.10
16.01%
19.36
28.22%
30.33
56.66%
38.88
28.20%
49.38
26.98%
85.22
72.61%
155.13
82.02%
129.70
16.39%
223.21
72.09%
249.93
11.97%
roe
0.11
-
0.15
39.33%
0.22
47.75%
0.25
12.31%
0.18
28.46%
0.18
4.40%
0.15
16.06%
0.25
61.39%
0.14
45.54%
0.20
48.49%
0.14
31.58%
roic
0.16
-
0.13
16.37%
0.21
59.78%
0.23
7.15%
0.22
1.72%
0.16
29.26%
0.14
11.82%
0.26
85.65%
0.10
61.59%
0.17
76.20%
0.12
28.88%
sales general and administrative to revenue
0.10
-
0.09
7.02%
0.08
13.91%
0.06
29.96%
0.06
10.19%
0.07
13.68%
0.06
9.78%
0.07
2.57%
shareholders equity per share
12.94
-
36.10
179.03%
59.58
65.05%
80.61
35.30%
103.10
27.90%
130.81
26.87%
223.12
70.57%
293.36
31.48%
339.41
15.70%
419.67
23.65%
479.56
14.27%
stock based compensation to revenue
0.02
-
0.03
87.01%
0.03
1.00%
0.03
9.25%
0.03
9.69%
0.03
6.60%
0.03
8.69%
0.02
27.79%
0.04
84.77%
0.03
17.70%
0.04
18.26%
tangible asset value
656.98M
-
1.97B
199.92%
3.29B
67.18%
4.64B
41.00%
6.15B
32.36%
7.54B
22.71%
13.58B
79.98%
18.78B
38.33%
21.94B
16.82%
27.30B
24.40%
31.51B
15.44%
tangible book value per share
12.89
-
34.99
171.49%
56.29
60.88%
77.57
37.81%
101.06
30.27%
123.13
21.84%
215.65
75.14%
288.18
33.63%
335.53
16.43%
417.44
24.41%
479.56
14.88%
working capital
785.48M
-
2.11B
168.67%
3.25B
54.17%
4.49B
37.89%
5.73B
27.78%
6.99B
21.93%
13.02B
86.32%
17.54B
34.67%
21.17B
20.70%
26.55B
25.44%
30.66B
15.44%

All numbers in (except ratios and percentages)